science and innovations
Production of Lutetium-177 for Nuclear Medicine to be Launched at TPU Reactor by the Year End
By the end of 2023, the nuclear research reactor of Tomsk Polytechnic University will launch a new system of protective boxes, which will enable specialists to produce the lutetium-177 isotope for nuclear medicine on an industrial scale using their own technology. This isotope is used by national hi-tech oncology centers to treat prostate cancer. The equipment was purchased with the support of the Priority 2030 program of the Russian Ministry of Science and Higher Education and the national project Science and Universities. Total cost of the new equipment is about 80 million rubles. The TPU reactor production facility will be the second one in Russia and will considerably increase the number of treatment procedures in the country.
